SUCAMPO PHARMACEUTICALS, INC. Accrued Liabilities, Current
SUCAMPO PHARMACEUTICALS, INC. had Accrued Liabilities, Current of $12.24 million as of 2017-09-30, per its 10-Q filed 2017-11-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2017-11-01
- 2017-09-30: Accrued Liabilities, Current $12.24M.
- 2017-06-30: Accrued Liabilities, Current $12.27M.
- 2017-03-31: Accrued Liabilities, Current $17.10M.
- 2016-12-31: Accrued Liabilities, Current $12.39M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2017-09-30 | $12.24M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $12.27M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $17.10M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $12.39M 10-Q · filed 2017-11-01 | |
| 2016-09-30 | $14.38M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $13.30M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $13.69M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $10.89M 10-K · filed 2017-03-08 | |
| 2015-09-30 | $10.15M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $8.66M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $9.66M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $8.47M 10-K/A · filed 2016-03-16 | |
| 2014-09-30 | $7.16M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $6.26M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $6.00M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $5.68M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $6.21M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $6.43M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $7.84M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $10.60M 10-K · filed 2014-03-12 | |
| 2012-09-30 | $8.80M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $9.23M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $7.17M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $13.65M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $18.53M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $18.54M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $13.65M 10-Q · filed 2012-08-09 | $10.22M 10-Q · filed 2011-08-05 |